Thursday, November 01, 2007

Viagra Relieves Pulmonary Hypertension.

Sept. 23, 2007 — viagra (sildenafil) causes preferential pulmonary vasodilation, according to results of an open-label tribulation published in the Sept. 21 publication of The Gothic arch.
The authors and editorialist therefore suggest that sildenafil may in the time to come become the drug of action for secondary coil pulmonary hypertension related to pulmonary fibrosis.
“Controlled randomized trials should be done to confirm our findings,” lead maker Hossein A.
Ghofrani, MD, from Establishment Infirmary in Giessen, Germany, says in a news promulgation. “However, the unique visibility of sildenafil , not previously shown for a systemically administered functionary, suggests that the drug is a promising politico for long-term aid of coil pulmonary hypertension in lung fibrosis.”
In this overture controlled endeavor, 16 individuals with pulmonary hypertension secondary coil to pulmonary fibrosis received nitric oxide intake and were then randomized to management with oral viagra or intravenous epoprostenol.
Only those patients who received viagra had a change in the quantitative relation of pulmonary to systemic vascular condition.
Both nitric oxide and viagra maintained ventilation/perfusion matching, and viagra raised arterial differential imperativeness of oxygen (14.3 mm Hg, 95% self-confidence separation, -1.7 to 31.3).
No adverse events were reported.
In an accompanying commentary, Raed A.
Dweik, from the INSTANCE OFPresident of the United States Health facility Basis in Ohio, notes that inhaled nitric oxide is highly effective in pulmonary hypertension, but that cost and unresolved pickup truck difficulties in birth have limited its use.
He writes that this composition “adds to growth grounds for the use of viagra … in patients with coil and secondary winding pulmonary hypertension.To date, this is the best available orally administered selective pulmonary vasodilator.”
This is a part of article Viagra Relieves Pulmonary Hypertension. Taken from "Viagra Levitra" Information Blog

No comments: